Predeposit autologous donation in spinal surgery: a multicentre study

European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
José A García-ErceJavier Vicente-Thomas

Abstract

Allogeneic blood transfusions (ABT) are often necessary in elective spine surgery because of perioperative blood loss. Preoperative autologous blood donation (PABD) has emerged as the principal means to avoid or reduce the need for ABT. Consequently, a multicentre study was conducted to determine the yield and efficacy of PABD in spine surgery and the possible role of recombinant human erythropoietin (EPO) in facilitating PABD. We retrospectively reviewed the hospital charts and blood bank records from all consecutive spine surgery patients who were referred for PABD. Data were obtained from two A-category hospital blood banks and one general hospital. Although we collected data from 1994, the analytic study period was from the last quarter of 1995 to December 2003. Fifty-four (7%) out of 763 patients referred for PABD were rejected, and medical records were available for 680 patients who were grouped into spinal fusion (556; 82%) and scoliosis surgery (124;18%). EPO was administered to 120 patients (17.6%). From 1999 to 2003, PABD steadily increased from 60 to 209 patients per year. Overall, 92% of the patients were able to complete PABD, 71% were transfused, and almost 80% avoided ABT. PABD was more effective in fusions (86%)...Continue Reading

References

May 1, 1992·Transfusion·M C FernandezJ E Menitove
Oct 1, 1993·Journal of Spinal Disorders·D G SeltzerF P Cammisa
Jan 23, 1999·International Orthopaedics·G ShulmanA G Hadjipavlou
Feb 24, 2001·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·C SebastiánM Muñoz
Jan 5, 2002·Transfusion·M E Brecher, L T Goodnough
Mar 16, 2002·Transfusion·Sean M BerenholtzMichael J Klag
Mar 30, 2002·BMJ : British Medical Journal·Elizabeth S VanderlindeNeil Blumberg
Apr 10, 2002·Transfusion Medicine Reviews·Eleftherios C Vamvakas
Oct 12, 2002·Transfusion·Mindy GoldmanMarc Germain
Dec 11, 2002·Transfusion·Manuel Muñoz, José A García-Erce
Dec 26, 2002·Anaesthesia and Intensive Care·K S LoK D K Luk
Mar 14, 2003·Spine·Gary S ShapiroLindy S Maier
Jul 3, 2003·Clinical Orthopaedics and Related Research·Ji-Ho LeeJoo Han Oh
Oct 1, 2003·The Journal of Bone and Joint Surgery. British Volume·S RidgewayD J Harrison
Nov 1, 2003·The Spine Journal : Official Journal of the North American Spine Society·Michael G VitaleDavid P Roye
Feb 27, 2004·Vox Sanguinis·A Farrugia

❮ Previous
Next ❯

Citations

Jun 19, 2012·Archives of Orthopaedic and Trauma Surgery·Raúl Torres-ClaramuntEnric Cáceres
May 13, 2004·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·M MuñozC Sebastián
Jan 29, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Robert C Mulholland
Jul 23, 2013·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Pilar SolvesMiguel Angel Sanz
Jun 8, 2015·Revista española de anestesiología y reanimación·A Pérez-FerrerF Gilsanz-Rodríguez
Nov 5, 2008·Spine·George H ThompsonJochen Son-Hing
Oct 2, 2007·Transfusion Medicine·UNKNOWN British Committee for Standards in Haematology, Transfusion Task ForceV James
Jun 24, 2017·The Journal of the American Academy of Orthopaedic Surgeons·Matthew E Oetgen, Jody Litrenta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.